Patrick Coppens is a dedicated and results-driven professional currently serving as the Manager des Formulations Ophtalmiques at Merck. With over 12 years of experience in production management, Patrick has honed his expertise in the pharmaceutical sector, particularly in the development and manufacturing of high-quality ophthalmic...
Patrick Coppens is a dedicated and results-driven professional currently serving as the Manager des Formulations Ophtalmiques at Merck. With over 12 years of experience in production management, Patrick has honed his expertise in the pharmaceutical sector, particularly in the development and manufacturing of high-quality ophthalmic solutions. His current role involves overseeing three specialized workshops: a sterile ophthalmic solution preparation area with preservatives, a fully renovated and requalified Unit Dose preparation facility, and a dispensing workshop where precision is paramount, with 90% of the processes involving meticulous weighing.
Patrick's commitment to delivering top-notch products on time and within budget is evident in his approach to project management and team leadership. He thrives in dynamic environments, where his tenacity and engagement drive continuous improvement and innovation. His proficiency in aseptic processing, regulatory affairs, and quality systems ensures that all operations adhere to stringent industry standards, while his adeptness in managing change control and corrective actions (CAPA) fosters a culture of compliance and excellence.
In addition to his technical skills, Patrick is known for his ability to seamlessly transition between roles and responsibilities, making him a versatile asset to any team. His passion for biotechnology and commitment to advancing ophthalmic formulations position him as a key player in Merck's mission to enhance patient outcomes through innovative healthcare solutions. With a focus on technological transfer and adherence to standard operating procedures (SOP), Patrick is dedicated to driving projects that not only meet but exceed the expectations of stakeholders and regulatory bodies alike.
